Search Within

Manish Shah

Formats
  1. Journal Article (89)
  2. Meeting Abstract (81)
  3. Book Whole (4)
  4. Book Section (3)
Groups
  1. Department of Medicine (115)
  2. Center for Pancreatic Cancer Research (112)
  3. Solid Tumor Oncology Division (112)
  4. Gastrointestinal Oncology Service (104)
  5. Epidemiology and Biostatistics (65)
  6. Biostatistics Service (64)

More Groups

People
  1. David Kelsen (88)
  2. Gary Schwartz (41)
  3. Laura Tang (39)
  4. David Ilson (35)
  5. Daniel Coit (32)
  6. Marinela Capanu (31)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2015 (4)
  5. 2014 (3)
  6. 2013 (11)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Clinical Cancer Research (11)
  3. Annals of Surgical Oncology (9)
  4. Journal of Gastrointestinal Cancer (6)
  5. Annals of Oncology (5)
  6. Cancer (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (73)
  2. Springer (25)
  3. American Association for Cancer Research (19)
  4. Elsevier Inc. (11)
  5. Lippincott Williams & Wilkins (8)
  6. Wiley Blackwell (7)

More Publishers

Results (177)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer prevention and early detection of gastric cancer: The role of the early onset and familial gastric cancer registry
    Meeting Abstract

    Randazzo, J.; Harlan, M.; Sheehy, E.; Shah, M.
    Oncology Nursing Forum (2007)

    Fulltext@MSK | Save
  • Does graded histologic response after neoadjuvaut treatment predict survival for completely resected gastric cancer?
    Meeting Abstract

    Mansour, J. C.; Tang, L.; Shah, M.; Bentrem, D.; Klimstra, D.; Gonen, M.; Brennan, M.; Coit, D.
    Annals of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Bevacizumab with chemotherapy in the treatment of advanced gastric and gastroesophageal junction adenocarcinoma
    Journal Article

    Shah, M. A.
    American Journal of Hematology/Oncology (2007)

    Fulltext@MSK | Save
  • Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Journal Article

    Mansour, J. C.; Tang, L.; Shah, M.; Bentrem, D.; Klimstra, D. S.; Gonen, M.; Kelsen, D. P.; Brennan, M. F.; Coit, D. G.
    Annals of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent
    Journal Article

    Gold, J. S.; Jaques, D. P.; Bentrem, D. J.; Shah, M. A.; Tang, L. H.; Brennan, M. F.; Coit, D. G.
    Annals of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Journal Article

    Fornier, M. N.; Rathkopf, D.; Shah, M.; Patil, S.; O'reilly, E.; Tse, A. N.; Hudis, C.; Lefkowitz, R.; Kelsen, D. P.; Schwartz, G. K.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Systemic chemotherapy does not increase the risk of gastrointestinal perforation
    Journal Article

    Asmis, T. R.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Advances in gastric cancer: What lies ahead
    Book Section

    Shah, M. A.; Ilson, D. H.
    In Macdonald, J. S. (Eds.) Advances in the Management of Gastric Cancer (2006)

    Fulltext@MSK | Save
  • Dx/Rx: Upper gastrointestinal malignancies: Cancers of the stomach and esophagus
    Book Whole

    Shah, M. A.
    Jones and Bartlett Publishers (2006)

    Fulltext@MSK | Save
  • Final results of a multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with metastatic gastric or gastroesophageal (GEJ) adenocarcinoma (NCI #6447)
    Meeting Abstract

    Shah, M. A.; Ramanathan, R. K.; Ilson, D.; Randazzo, J.; Schwartz, G. K.; Tse, A.; D'adamo, D.; Levner, A.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save